Changes produced by clofibrate in hepatocytes of rats with sucrose-induced hyperlipidemia.
D000818:Animals; D002994:Clofibrate / Q000494:pharmacology*; D004721:Endoplasmic Reticulum / Q000473:pathology; D006003:Glycogen / Q000378:metabolism; D006056:Golgi Apparatus / Q000473:pathology; D006949:Hyperlipidemias / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D008079:Lipoproteins, VLDL / Q000378:metabolism*; D008099:Liver / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008247:Lysosomes / Q000473:pathology; D008297:Male; D008830:Microbodies / Q000473:pathology; D008854:Microscopy, Electron; D008930:Mitochondria, Liver / Q000473:pathology; D008954:Models, Biological; D051381:Rats; D013395:Sucrose; D014280:Triglycerides / Q000378:metabolism
D008079:Lipoproteins, VLDL; D014280:Triglycerides; D013395:Sucrose; D006003:Glycogen; D002994:Clofibrate